Company Coverage
TA: Swire Pacific (0019 HK) / JD Health International (6618 HK)
Analyst


Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/0e6d602f-adeb-45f8-9dea-5d5591daae87, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Related articles
28 Oct 2026
TA: Swire Properties (1972 HK) / CK Hutchison (0001 HK)
16 Oct 2026
TA: SITC International (1308 HK) / China Hongqiao Group (1378 HK)
5 Nov 2026
TA: Hansoh Pharmaceutical Group (3692 HK) / Zijin Gold International (2259 HK)
Our latest research

6 Nov 2026
BeOne Medicines (6160 HK) - 3Q26: Results Outperform; Raising 2026 Guidance Again

6 Nov 2026
ECARX Holdings Inc (ECX US) - 3Q26: Memory Costs Cut Gross Margin To 7.0%

6 Nov 2026
